Many trials exclude certain groups, and do so deliberately—children, for example, or people with physical or learning ...

The partnership focuses on healthcare research, development, and innovation policies. Itqan Clinical Simulation and ...

A healthcare scientist at Royal Bolton Hospital has been honoured for dedicating more than 20 years of her career to ...

New research shows that a combined effort of mailing stool-based tests and providing patient navigation to follow-up ...

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that ...

The first patient has been enrolled in the PROSTATE-IQ trial of ArteraAI, a multimodal artificial intelligence biomarker test ...

This review discusses the current state of multicancer early detection tests, the role of machine learning in their ...

Philip Bergman, DVM, MS, PhD, DACVIM (Oncology), kicked off the 2025 Fetch Charlotte conference with his keynote address on ...

We have written at length about the U.S. Food and Drug Administration’s (FDA’s) actions to promulgate regulations specifying the agency’s authority ...

The firm is preparing for a trial to show the efficacy of its CyPath Lung test and support a submission to the US Food and Drug Administration for marketing clearance.

Sponsored genetic testing programs can run afoul of federal laws, including the FCA and AKS, if not designed correctly.

By Rose Miyatsu The Colligan Clinical Diagnostic Laboratory (CCDL) has received its CLIA certificate of registration from the ...